Detalhe da pesquisa
1.
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders.
Neurol Neuroimmunol Neuroinflamm
; 7(5)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503092
2.
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study.
Chin Med J (Engl)
; 131(23): 2776-2784, 2018 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511679